Patent Holder Sues Regeneron & Pfizer & BioNTech Over Use of Proprietary ‘mNeonGreen’ Tech for COVID-19
Much attention has gone to Regeneron and the monoclonal antibody cocktail known as REGN-CoV2, especially given the investigational drug was […]
BioNTech & Pfizer’s BNT162b2 Now Under Rolling Submission Status by EMA: Means COVID-19 Vaccine Could Get Approved Faster
The COVID-19 vaccine candidate known as BNT162b2 may be getting closer to registration (e.g. approval) as the European Medicines Agency […]
Pfizer Opted Not to Take Feds Money to ‘Liberate Scientists from any Bureaucracy’
Pfizer’s CEO Albert Bourla joined Martha Brennan with CBS Face the Nation. An interesting character, he’s not just the standard […]
Is the Pfizer & BioNTech Partnership Positioning to be First with COVID-19 Vaccine 1.0 while Also Developing the Lead for 2.0?
Daina Graybosch, a top life science research analyst at SVB Leerink covering Immuno-Oncology, recently communicated to investors that Pfizer and partner […]
Salt Lake City’s Foothill Family Clinic Rapidly Enrolls Vaccine Participants for Two Phase 3 Clinical Trials
Thanks to a partnership with J Lewis Research, healthcare provider Foothill Family Clinic in Salt Lake City, Utah, is conducting two Phase […]
Aventiv Research Shows Progress in Enrolling Volunteers for BNT162 Vaccine Trial in Columbus, Ohio
TrialSite recently reported on privately-held Aventiv Research Inc. as the only trial site organization in this part of Central Ohio to […]
Pfizer’s BNT162b2 COVID-19 Vaccine Phase 2/3 Clinical Trial Comes to University Hospitals Cleveland Medical Center
“Project Lightspeed” is coming to University Hospitals Cleveland Medical Center (UH) to conduct the pivotal Phase 2/3 global clinical trial […]
Pfizer BNT162 COVID-19 Vaccine Trial Comes to Nashville’s Davidson County Public Health Department
The Project Lightspeed initiative has come to Nashville, Tennessee. Clinical Research Associates, a trial site organization was selected by Pfizer to […]
Yale Shows a Path Forward for Research
New Haven, Connecticut, like many American cities, represents a multiplicity of reality exemplifying economic, social, cultural, and demographic diversity—that can […]
Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial: Volunteers Drive 2 Hours to Contribute
Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial […]
